The awards symposium was chaired by Professor David Bates, Emeritus Professor of Clinical Neurology, Royal Victoria Infirmary, UK and a member of the GMSI
En esta revision se intenta dar una actualizacion sobre GMSI y una vision global sobre las distintas entidades asociadas a paraproteinas monoclonales (Figura 2).
El diagnostico de GMSI requiere la presencia de tres criterios: paraproteina monoclonal menor a 3 g/dL, plasmocitosis medular menor a 10% y ausencia de dano de organos blanco asociados a mieloma (CRAB: hipercalcemia, falla renal, anemia y lesiones oseas).
La evaluacion de todo paciente con GMSI debe incluir una completa evaluacion clinica, una detallada caracterizacion de la paraproteina monoclonal, una evaluacion de la masa tumoral y la busqueda sistematica de evidencias de dano de organos blanco.
The products resulting from the appliction of chemical vapor deposited (CVD) silicon carbide ceramic coating on precision machined graphite shapes through the method developed by GMSI are used in the manufacturing of light emitting diodes (LEDs) aimed at the fast-growing solid state lighting sector, the buyer said.
For GMSI, the transaction brings a resourceful partner which can support its future expansion in the growing LED markets, president Peter Guercio said.
Ceradyne makes and sells advanced technical ceramic products and components aimed at applications in such sectors as defense, industrial, energy, automotive/diesel, and commercial.Country: USASector: ElectronicsTarget: Graphite Machining Services and Innovations LLC (GMSI)Buyer: Ceradyne IncType: Corporate acquisition, StakebuildingStatus: Agreed, Exclusivity
The GMSI is a six-item instrument that contains Likert statements scored on a seven-point disagree-agree type scale.
The measure for situation of symbolic interaction in this study (as captured by Traylor and Joseph's, 1984 GMSI) combined the importance of self-concept and situations and reflected the manner in which involvement with reference group members in the social setting influenced individuals' self-concept.
The awards symposium was chaired by David Bates, Emeritus Professor of Clinical Neurology at the University of Newcastle upon Tyne (UK), and a member of the GMSI Scientific Committee.
The second-year recipients of the GMSI will help us to continue accelerating exceptional science that demonstrates the potential to become an innovative medicine or a high-value solution for people living with multiple sclerosis.
The GMSI was launched in October 2012 at the 28th ECTRIMS Congress with the aim of improving the understanding of MS for the ultimate benefit of those living with the disease.